Skip to main content

Table 2 Patient demographic and clinical characteristics in the full sample

From: Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe

Characteristic Overall (N = 1542)
Mean ± SD age, years 60.8 ± 16.5
Male, n (%) 949 (61.5)
White, n (%) 1432 (92.9)
Mean ± SD CCI score 2.3 ± 2.2
Primary reason for hospitalization is treatment of MRSA cSSTI, n (%) 1249 (81.0)
Timing of cSSTI index date, n (%)  
  At hospital admission 1282 (83.1)
  1–3 days after admission 49 (3.2)
  ≥4 days after admission 211 (13.7)
Type of cSSTI, n (%)  
  Surgical site infection or posttraumatic wound 400 (25.9)
  Major abscess 271 (17.6)
  Infected ulcer 381 (24.7)
  Deep or extensive cellulitis 406 (26.3)
  Other (including infected burn) 84 (5.4)
cSSTI location, n (%)  
  Head/skull/neck 63 (4.1)
  Torso/abdomen 325 (21.1)
  Upper extremity 232 (15.0)
  Lower extremity 922 (59.8)
Sepsis, severe sepsis, or septic shock during cSSTI episode, n (%) 265 (17.2)
Surgical procedures for treatment of cSSTI, n (%) 597 (38.7)
Mean ± SD number of procedures among patients with any procedures 0.4 ± 0.6
Patient switched from IV-to-oral inpatient MRSA-active antibiotic treatment, n (%) 197 (12.8)
Patient received MRSA-targeted therapy at discharge, n (%) 514 (33.3)
  1. Abbreviations: CCI, Charlson comorbidity index; cSSTI, complicated skin and soft tissue infection; IV, intravenous; MRSA, methicillin-resistant Staphylococcus aureus; SD, standard deviation.